EC approves Libtayo® for metastatic cervical cancer
The European Commission has approved Libtayo® for cervical cancer and…
The European Commission has approved Libtayo® for cervical cancer and disease progression while on or after platinum-based chemotherapy, due to positive Phase III trial results.